Rujuta Bhatt Wilson is assistant professor of pediatrics and psychiatry at the Semel Institute of Neuroscience and Human Behavior at the University of California, Los Angeles.
Rujuta Bhatt Wilson
Assistant professor
University of California, Los Angeles
From this contributor
A new look at walking in early childhood: Q&A with Rujuta Wilson
Quantifying toddlers’ gaits promises to improve autism diagnosis and intervention.
A new look at walking in early childhood: Q&A with Rujuta Wilson
By
Charles Q. Choi
14 March 2024 | 6 min read
Quantitative tests of motor skills could improve autism care
New assessments of the subtle motor difficulties that characterize autism could improve autistic children's lives and teach us a lot about the condition.
Quantitative tests of motor skills could improve autism care
By
Rujuta Bhatt Wilson
2 April 2019 | 6 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read